MARC details
000 -LEADER |
fixed length control field |
01572cam a2200373 a 4500 |
001 - CONTROL NUMBER |
control field |
925344 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20210921175327.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
980326s1998 dcua b 101 0 eng |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780841235670 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780841235670 : |
Terms of availability |
No price |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)38925344 |
Canceled/invalid control number |
(OCoLC)40981407 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
Transcribing agency |
DLC |
Modifying agency |
AGL |
-- |
NLM |
-- |
UKM |
-- |
LVB |
-- |
BAKER |
-- |
BTCTA |
-- |
YDXCP |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.19 |
Item number |
AME |
110 2# - MAIN ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
American Chemical Society meeting : |
Number of part/section/meeting |
213th : |
Date of meeting or treaty signing |
April 13-17, 1997 : |
Location of meeting |
San Francisco, Ca. |
245 10 - TITLE STATEMENT |
Title |
Validation of biopharmaceutical manufacturing processes / |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Washington, D.C. : |
Name of publisher, distributor, etc. |
American Chemical Society, |
Date of publication, distribution, etc. |
c1998. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
x, 191 p. : |
Other physical details |
ill. ; |
Dimensions |
24 cm. |
336 ## - CONTENT TYPE |
Content type term |
text |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
unmediated |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
volume |
Source |
rdacarrier |
490 #0 - SERIES STATEMENT |
Series statement |
ACS symposium series ; |
Volume/sequential designation |
698 |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and indexes. |
520 8# - SUMMARY, ETC. |
Summary, etc. |
This reference on the validation of biopharmaceutical manufacturing processes describes all aspects of process validation in the licensure of recombinant biologics, for both protein and non-protein products. It covers product synthesis, purification, and filling/finishing. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmaceutical biotechnology |
General subdivision |
Congresses. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Kelley, Brian D., |
Titles and other words associated with a name |
1964- |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Ramelmeier, R. Andrew. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
American Chemical Society. |
Subordinate unit |
Division of Biochemical Technology. |
902 ## - LOCAL DATA ELEMENT B, LDB (RLIN) |
a |
150413 |
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) |
a |
.b10511295 |
b |
smmai |
c |
- |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Suppress in OPAC |
0 |
948 ## - LOCAL PROCESSING INFORMATION (OCLC); SERIES PART DESIGNATOR (RLIN) |
h (OCLC) |
NO HOLDINGS IN LQI - 150 OTHER HOLDINGS |
998 ## - LOCAL CONTROL INFORMATION (RLIN) |
Operator's initials, OID (RLIN) |
0 |
Cataloger's initials, CIN (RLIN) |
081203 |
First Date, FD (RLIN) |
m |
Local |
a |
-- |
0 |